The Impact of Subthalamic Deep Brain Stimulation on Sleep in Patients with Parkinson’s Disease: A Systematic Review and Meta-analysis
Maria Antonia Machado Pereira1, Izabely Dos reis de paula1, Hilaria Faria2, Marcelo Sousa3, Ocilio Goncalves4, Vitor Ribeiro4, Vitoria Pinheiro5, Pedro Borges6, Elizabet Taylor Weba7, Breno Alencar8, Marcio Ferreira9, Venkateshwaran Vijayanarasimhan10, Sanjeet Grewal11, Denise Maria Cury12, Gustavo Noleto13
1State University of Piauí, 2Federal University of Santa Maria, 3Federal University of Rio de Janeiro, 4Federal University of Piauí, 5Ninth of July University, 6Neuroscience, D'Or Institute for Research and Education, 7State University of Região Tocantina do Maranhão, 8Zarns University, 9Neurosurgery, Lenox Hill Hospital/Northwell, 10Neurosurgery, Mayo Clinic, 11Mayo Clinic, 12Federal University of Minas Gerais, 13University of São Paulo
Objective:

We aim to conduct a systematic review and meta-analysis to assess the postoperative effects of Subthalamic Deep Brain Stimulation (STN-DBS) on sleep quality in patients with Parkinson’s Disease (PD)


Background:

STN-DBS is an effective adjunctive therapy for managing motor symptoms in  PD. However, its effect on sleep disturbances is not widely understood.


Design/Methods:

Pubmed, Embase, Scopus, and Web of Science were searched for randomized and non-randomized studies enrolling patients with PD who received DBS surgery. The outcomes of interest were the mean changes between the pre- and post-operative values of the Parkinson's Disease Sleep Scale (PDSS), REM sleep, total sleep time, sleep efficiency, Epworth Sleepiness Scale (ESS), and Wakefulness After Sleep Onset (WASO). Mean differences (MD) with 95% confidence intervals (CI) with a random effects model were used. The statistical analyses were performed using the software R Studio version 4.4.2. 


Results:

Twenty-three studies were included in this meta-analysis, comprising 799 patients who underwent DBS. Follow-up ranged between 3 to 52 months. There was no significant difference between pre- and post-operative time in REM sleep (MD 13.32; CI -2.19 to 28.82; p = 0.09), ESS (MD -1.35; 95% CI -2.93 to 0.22; p = 0.09), total sleep time (MD 24.99; 95% CI: -14.74 to 64.73; p = 0.22), sleep efficiency (MD 3.85; 95% CI -4.40 to 12.10; p = 0.36), WASO (MD -35.87; 95% CI -79.59 to 7.84; p = 0.11). However, PDSS (MD 17.09; 95% CI: 12.31 to 21.86; p < 0.01) was significantly higher postoperatively compared to the preoperative period in these patients.


Conclusions:

This meta-analysis reveals that DBS has a limited impact on overall sleep outcomes in PD patients.


10.1212/WNL.0000000000212279
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.